Skip to main content
. 2020 Aug 4;10:1312. doi: 10.3389/fonc.2020.01312

Figure 1.

Figure 1

Various modality tumor genome-transcriptome-proteome analysis. (A) Tissue sampling via biopsy or peripheral blood sample. (B) Modality for tissue analysis via DNA, RNA, protein. (C) Results of identified biomarker in NGS, RNAseq, IHC, ctDNA for targeted therapy approach.